0 cm, patency was superior in the
PTFE group. This study was ﬂawed by protocol violations
in >8% of cases.

JOURNAL OF VASCULAR SURGERY
March Supplement 2015

The Viabahn vs Bare Nitinol Stent in the Treatment of
Long Lesion Superﬁcial Femoral Artery Occlusive Disease
(VIBRANT) trial randomized 148 patients to PTFE
covered or